Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | ACP3 | P15309 | 2/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28014617 | 0.81 | LMNA (0.48) | LMNAMAPK1ALDH1A1KMT2ACES2 | |
| SCHEMBL366884 | 0.80 | ALPI (0.56) | — | |
| SCHEMBL20424193 | 0.80 | SMN1; SMN2 (0.44) | MAPTALDH1A1KMT2AMEN1L3MBTL1 | |
| SCHEMBL9617184 | 0.79 | MAPT (0.43) | LMNAMAPK1MAPTALDH1A1BCHE | |
| SCHEMBL8876742 | 0.78 | LMNA (0.54) | LMNAMAPK1ALDH1A1KMT2AMEN1 | |
| SCHEMBL2806899 | 0.78 | LMNA (0.46) | LMNAMAPK1ALDH1A1KMT2ACES2 | |
| SCHEMBL6429495 | 0.77 | THRB (0.48) | LMNAALDH1A1KMT2AMEN1CYP2C19 | |
| SCHEMBL11176841 | 0.77 | THRB (0.48) | LMNAALDH1A1KMT2AMEN1CYP2C19 | |
| SCHEMBL536227 | 0.77 | ALDH1A1 (0.55) | LMNAMAPK1ALDH1A1KMT2ACES2 | |
| SCHEMBL5117818 | 0.77 | ALDH1A1 (0.55) | LMNAMAPK1ALDH1A1KMT2ACES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1082293-B1 | FORMOTEROL POLYMORPHS | SEPRACOR INC (US) | 2004-02-18 | — | — | EP | disclosed |
| EP-1093450-B1 | DESFORMOTEROL AND PROCESS FOR ITS PREPARATION | SEPRACOR INC (US) | 2003-04-23 | — | — | EP | disclosed |
| EP-0938467-B1 | PROCESS FOR THE PREPARATION OF OPTICALLY PURE ISOMERS OF FORMOTEROL | SEPRACOR INC (US) | 2002-06-12 | — | — | EP | disclosed |
| US-6268533-B1 | REACTING 4-BENZYLOXY-3-FORMAMIDOSTYRENE OXIDE WITH AN OPTICALLY PURE 4-METHOXY-.ALPHA.-METHYL-N-(PHENYLMETHYL)BENZENEETHANAMINE FOLLOWED BY REDUCTION TO PRODUCE FORMOTEROL | SEPRACOR INC. | 2001-07-31 | — | — | US | disclosed |
| EP-1093450-A1 | DESFORMOTEROL AND PROCESS FOR ITS PREPARATION | Sepracor Inc. (US) | 2001-04-25 | — | — | EP | disclosed |
| EP-1082293-A2 | FORMOTEROL POLYMORPHS | Sepracor Inc. (US) | 2001-03-14 | — | — | EP | disclosed |
| US-6071971-A | FOR TREATING PULMONARY DISORDERS | SEPRACOR INC. (US) | 2000-06-06 | — | — | US | disclosed |
| WO-2000021487-A2 | FORMOTEROL POLYMORPHS | SEPRACOR INC. (US) | 2000-04-20 | — | — | WO | disclosed |
| US-6040344-A | CRYSTALLINE R,R-FORMOTEROL L-(+)-TARTRATE. | SEPRACOR INC. (US) | 2000-03-21 | — | — | US | disclosed |
| WO-1999067198-A1 | DESFORMOTEROL AND PROCESS FOR ITS PREPARATION | SEPRACOR INC. (US) | 1999-12-29 | — | — | WO | disclosed |
| US-5965622-A | BRONCHODILATORS; HIGHLY SELECTIVE BETA 2-ADRENERGIC RECEPTOR AGONIST; RESPIRATORY DISORDERS, E.G. ASTHMA, BRONCHITIS; REDUCTION OF A PROTECTED NITRO DERIVATIVE; STEREOSPECIFIC | SEPRACOR INC. (US) | 1999-10-12 | — | — | US | disclosed |
| EP-0938467-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY PURE ISOMERS OF FORMOTEROL | SEPRACOR, INC. (US) | 1999-09-01 | — | — | EP | disclosed |
| WO-1998021175-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY PURE ISOMERS OF FORMOTEROL | SEPRACOR, INC. (US) | 1998-05-22 | — | — | WO | disclosed |